From January 1, 2024 to March 31, 2024, the company has repurchased 1,148,000 shares, representing 0.67% for CNY 13.11 million. With this, the company has completed the repurchase of 1,872,500 shares, representing 1.1% for CNY 22.08 million under the buyback announced on May 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.18 CNY | +3.50% | +0.14% | -2.68% |
1st Jan change | Capi. | |
---|---|---|
-2.68% | 321M | |
+17.10% | 8.43B | |
+14.30% | 6.82B | |
-3.69% | 3.77B | |
-7.34% | 3.74B | |
+1.78% | 1.44B | |
-28.77% | 1.06B | |
+18.84% | 1.04B | |
-11.81% | 890M | |
-18.34% | 812M |
- Stock Market
- Equities
- 603079 Stock
- News Zhejiang Shengda Bio-Pharm Co., Ltd.
- Tranche Update on Zhejiang Shengda Bio-Pharm Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.